1529-0131/asset/cover.gif?v=1&s=104d5c2bb8ef72deba26790b855af7ab80697a0e "Arthritis & Rheumatism")
Direct Link:
1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Research Article
You have full text access to this OnlineOpen article
Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skin
Article first published online: 5 AUG 2004
DOI: 10.1002/art.20362
Copyright © 2004 by the American College of Rheumatology
Additional Information
How to Cite
Jiménez, S. A., Artlett, C. M., Sandorfi, N., Derk, C., Latinis, K., Sawaya, H., Haddad, R. and Shanahan, J. C. (2004), Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skin. Arthritis & Rheumatism, 50: 2660–2666. doi: 10.1002/art.20362
Publication History
- Issue published online: 5 AUG 2004
- Article first published online: 5 AUG 2004
- Manuscript Accepted: 1 APR 2004
- Manuscript Received: 7 NOV 2003
Funded by
- NIH. Grant Number: AR-19161
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 6
- You have free access to this content2, , , , , , , , , , , , , , , Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide, British Journal of Pharmacology, 2012, 165, 4bDirect Link:
- 3, , , , , , , “Carcinoid-Like” Tricuspid Valvulopathy Associated with Nephrogenic Systemic Fibrosis, Echocardiography, 2011, 28, 3Direct Link:
- 4, , , , , , , , , Clinical, Biological, and Skin Histopathologic Effects of Ionic Macrocyclic and Nonionic Linear Gadolinium Chelates in a Rat Model of Nephrogenic Systemic Fibrosis, Investigative Radiology, 2011, 46, 2, 85
- 5, Dendritic Cells: Novel Players in Fibrosis and Scleroderma, Current Rheumatology Reports, 2011, 14, 1, 30
- 6
- 7, , , , Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review, Nephrology Dialysis Transplantation, 2011, 26, 11, 3616
- 8
- 9, Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents, Advances in Chronic Kidney Disease, 2011, 18, 3, 188
- 10, , , , , , , , , , Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis, Journal of the European Academy of Dermatology and Venereology, 2011, 25, 6Direct Link:
- 11, , , Pathomechanisms of nephrogenic systemic fibrosis: new insights, Clinical and Experimental Dermatology, 2011, 36, 7Direct Link:
- 12, , , , , Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: AÂ diagnostic aid, Journal of the American Academy of Dermatology, 2011, 64, 4, 741
- 13, , SÃndromes esclerodermiformes y estados seudoesclerodérmicos, EMC - DermatologÃa, 2011, 45, 4, 1
- 14, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy, Canadian Journal of Cardiology, 2011, 27, 4, 415
- 15, , , , , , , , , The Role of Residual Gadolinium in the Induction of Nephrogenic Systemic Fibrosis-Like Skin Lesions in Rats, Investigative Radiology, 2011, 46, 1, 48
- 16, , , , Tyrosine kinases in inflammatory dermatologic disease, Journal of the American Academy of Dermatology, 2011, 65, 2, 389
- 17
- 18
- 19, , , A Difficult Airway in a Patient with Nephrogenic Sclerosing Fibrosis, Anesthesia & Analgesia, 2010, 110, 2, 555
- 20, , , , , , , Balance of Profibrotic and Antifibroting Signaling in Nephrogenic Systemic Fibrosis Skin Lesions, American Journal of Kidney Diseases, 2010, 55, 6, 1040
- 21, , , , , , , , , , Comparison of half-dose and full-dose gadolinium MR contrast on the enhancement of bone and soft tissue tumors, Skeletal Radiology, 2010, 40, 3, 327
- 22, , , , Gadolinium-promoted precipitation of calcium phosphate is associated with profibrotic activation of RAW 264.7 macrophages, Toxicology in Vitro, 2010, 24, 6, 1743
- 23, , , Proteomic Analysis Identification of a Pattern of Shared Alterations in the Secretome of Dermal Fibroblasts from Systemic Sclerosis and Nephrogenic Systemic Fibrosis, The American Journal of Pathology, 2010, 177, 4, 1638
- 24, , Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis, Current Opinion in Rheumatology, 2010, 22, 6, 690
- 25, , , , , , The imbalanced expression of matrix metalloproteinases in nephrogenic systemic fibrosis, Journal of the American Academy of Dermatology, 2010, 63, 3, 483
- 26
- 27, , , , , , , , , Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes, Experimental Dermatology, 2009, 18, 12Direct Link:
- 28, , , Fibrose systémique néphrogénique, Annales de Dermatologie et de Vénéréologie, 2009, 136, 4, 380
- 29, , , Function and dysfunction of dendritic cells in autoimmune rheumatic diseases, Human Immunology, 2009, 70, 5, 360
- 30, , , , , Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: Critical review of the literature and UK experience, Journal of Magnetic Resonance Imaging, 2009, 29, 4Direct Link:
- 31, , , , , , Imatinib in the Treatment of Nephrogenic Systemic Fibrosis, American Journal of Kidney Diseases, 2009, 53, 1, 129
- 32, Imatinib Mesylate Treatment of Nephrogenic Systemic Fibrosis, Yearbook of Dermatology and Dermatologic Surgery, 2009, 2009, 297
- 33, , , Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents, Arthritis & Rheumatism, 2009, 60, 5Direct Link:
- 34
- 35, , Mechanism of NSF: New evidence challenging the prevailing theory, Journal of Magnetic Resonance Imaging, 2009, 30, 6Direct Link:
- 36
- 37, , , , , , Nephrogenic systemic fibrosis in a patient with a p-ANCA systemic vasculitis, ReumatologÃa ClÃnica, 2009, 5, 6, 264
- 38, , , , , Nephrogenic systemic fibrosis in liver disease: A systematic review, Journal of Magnetic Resonance Imaging, 2009, 30, 6Direct Link:
- 39, , , Nephrogenic systemic fibrosis: Clinical spectrum of disease, Journal of Magnetic Resonance Imaging, 2009, 30, 6Direct Link:
- 40, , Nephrogenic Systemic Fibrosis: Histology and Gadolinium Detection, Radiologic Clinics of North America, 2009, 47, 5, 841
- 41
- 42, , , , , Risk factors for NSF: A literature review, Journal of Magnetic Resonance Imaging, 2009, 30, 6Direct Link:
- 43, , , , , , , , The Evolution of Osseous Metaplasia in Localized Cutaneous Nephrogenic Systemic Fibrosis: A Case Report, The American Journal of Dermatopathology, 2009, 31, 7, 674
- 44, , , , , , A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast Media, Investigative Radiology, 2008, 43, 1, 65
- 45
- 46, , , Clinical and histological findings in nephrogenic systemic fibrosis, European Journal of Radiology, 2008, 66, 2, 191
- 47, , , Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation, Clinical Transplantation, 2008, 22, 6Direct Link:
- 48, , , , , Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: Three case reports and review of literature, Journal of Clinical Apheresis, 2008, 23, 4Direct Link:
- 49, , , Gadolinium and nephrogenic systemic fibrosis: Association or causation (Review Article), Nephrology, 2008, 13, 3Direct Link:
- 50, , Imatinib mesylate treatment of nephrogenic systemic fibrosis, Arthritis & Rheumatism, 2008, 58, 8Direct Link:
- 51, Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents, Pediatric Nephrology, 2008, 23, 12, 2121
- 52, Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting, European Journal of Radiology, 2008, 66, 2, 230
- 53, , , , , , Nephrogenic Systemic Fibrosis Associated with Gadolinium Use, Journal of the Formosan Medical Association, 2008, 107, 3, 270
- 54, , , Nephrogenic systemic fibrosis is associated with transforming growth factor β and Smad without evidence of renin-angiotensin system involvement, Journal of the American Academy of Dermatology, 2008, 58, 6, 1025
- 55, , , , Nephrogenic systemic fibrosis: a histopathological study of eight cases of a recently described entity, Histopathology, 2008, 52, 4Direct Link:
- 56, , , , Nephrogenic systemic fibrosis: an emerging entity, International Urology and Nephrology, 2008, 40, 3, 715
- 57, , Nephrogenic systemic fibrosis: An epidemic of gadolinium toxicity, Current Rheumatology Reports, 2008, 10, 3, 195
- 58, , Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature, Skeletal Radiology, 2008, 37, 5, 457
- 59, Nephrogenic systemic fibrosis: Possible mechanisms and imaging management strategies, Journal of Magnetic Resonance Imaging, 2008, 28, 4Direct Link:
- 60, , NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis Risk: Is There a Difference between Gadolinium-Based Contrast Agents?, Seminars in Dialysis, 2008, 21, 2Direct Link:
- 61, , , NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Treatment of Nephrogenic Systemic Fibrosis: Limited Options but Hope for the Future, Seminars in Dialysis, 2008, 21, 2Direct Link:
- 62, , , , Progressive arm and leg stiffness in a patient with chronic renal impairment, Nature Clinical Practice Rheumatology, 2008, 4, 10, 557
- 63, , , Quantification of gadolinium in nephrogenic systemic fibrosis: Re-examination of a reported cohort with analysis of clinical factors, Journal of the American Academy of Dermatology, 2008, 59, 2, 218
- 64
- 65, The Impact of NSF on the Care of Patients With Kidney Disease, Journal of the American College of Radiology, 2008, 5, 1, 45
- 66, What Causes Nephrogenic Systemic Fibrosis?, Dialysis & Transplantation, 2008, 37, 3Direct Link:
- 67, , , Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?, Wiener klinische Wochenschrift, 2007, 119, 9-10, 271
- 68, , , , Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposure, Arthritis & Rheumatism, 2007, 56, 10Direct Link:
- 69, , , , Fibrose systémique néphrogénique et produits à base de gadolinium : données disponibles début 2007, Thérapie, 2007, 62, 2, 169
- 70, , , , Gadolinium and nephrogenic systemic fibrosis: time to tighten practice, Pediatric Radiology, 2007, 38, 5, 489
- 71, , , Gadolinium Is Not the Only Trigger for Nephrogenic Systemic Fibrosis: Insights From Two Cases and Review of the Recent Literature, American Journal of Transplantation, 2007, 7, 10Direct Link:
- 72
- 73
- 74, , Nephrogene systemische Fibrose (NSF) nach Applikation gadoliniumhaltiger Kontrastmittel bei Shuntpatienten, Gefässchirurgie, 2007, 12, 6, 449
- 75, , , , Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature, International Journal of Dermatology, 2007, 46, 5Direct Link:
- 76
- 77, Nephrogenic systemic fibrosis and gadolinium-based contrast agents, Expert Review of Dermatology, 2007, 2, 5, 593
- 78, , , , , , Nephrogenic Systemic Fibrosis with Multiorgan Involvement in a Teenage Male After Lymphoma, Ewing's Sarcoma, End-Stage Renal Disease, and Hemodialysis, Pediatric and Developmental Pathology, 2007, 10, 5, 395
- 79, , , , , , , , Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor, British Journal of Dermatology, 2007, 157, 4Direct Link:
- 80, , , , , , , , Nephrogenic systemic fibrosis: A clinicopathologic study of six cases, Journal of the American Academy of Dermatology, 2007, 57, 1, 105
- 81, Nephrogenic Systemic Fibrosis: A Review and Exploration of the Role of Gadolinium, Advances in Dermatology, 2007, 23, 131
- 82, , The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses, Laboratory Investigation, 2007, 87, 9, 858
- 83, , , , , , Transglutaminases: The Missing Link in Nephrogenic Systemic Fibrosis, The American Journal of Dermatopathology, 2007, 29, 5, 433
- 84, , What nephrologists need to know about gadolinium, Nature Clinical Practice Nephrology, 2007, 3, 12, 654
- 85, , , , , , Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the Literature, Seminars in Arthritis and Rheumatism, 2006, 35, 4, 238
- 86, Nephrogenic Fibrosing Dermopathy, American Journal of Clinical Dermatology, 2006, 7, 4, 237
- 87, , , , Nephrogenic fibrosing dermopathy and calciphylaxis with pseudoxanthoma elasticum-like changes, Journal of Cutaneous Pathology, 2006, 33, 10Direct Link:
- 88, , , , Nephrogenic fibrosing dermopathy with involvement of the dura mater, Virchows Archiv, 2006, 449, 3, 389
- 89, , , Nephrogenic fibrosing dermopathy: A series in a non-Western population, Journal of the American Academy of Dermatology, 2006, 54, 1, 155
- 90, , , , Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis in 2 Patients With End-Stage Renal Disease on Hemodialysis, JCR: Journal of Clinical Rheumatology, 2006, 12, 3, 134
- 91, , , , , Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure, Journal of the American Academy of Dermatology, 2006, 54, 2, S31
- 92, , , Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis—Setting the Record Straight, Seminars in Arthritis and Rheumatism, 2006, 35, 4, 208
- 93, , , Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy), Current Opinion in Rheumatology, 2006, 18, 6, 614
- 94, , New Clinical Syndromes in Dermatology, Seminars in Cutaneous Medicine and Surgery, 2006, 25, 2, 79
- 95
- 96Case 35-2004: Nephrogenic Fibrosing Dermopathy, New England Journal of Medicine, 2005, 352, 16, 1723
- 97, , , Dermatopathology Update of “Newer†Dermatologic Manifestations of Systemic Disease, Advances in Dermatology, 2005, 21, 101
- 98, , , , Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema, Journal of Cutaneous Pathology, 2005, 32, 7Direct Link:
- 99, , , , Nephrogenic Fibrosing Dermopathy, a New Mimicker of Systemic Sclerosis, The American Journal of the Medical Sciences, 2005, 330, 4, 192
- 100, , , Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis: Report of a New Case With Literature Review, American Journal of Kidney Diseases, 2005, 46, 4, 754
- 101, , , , , , , , , Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy), Muscle & Nerve, 2004, 30, 5Direct Link:
- 102, , , Cutaneous Diseases and the Esophagus,Direct Link: